Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 2 5 IN PLASTIC CONTAINER versus DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 2 5 IN PLASTIC CONTAINER versus DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER.
DEXTROSE 2.5% IN PLASTIC CONTAINER vs DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that provides a source of glucose, which is metabolized to produce adenosine triphosphate (ATP) via glycolysis and the Krebs cycle. It serves as a carbohydrate caloric agent to prevent or treat hypoglycemia and provide parenteral nutrition.
Dextrose provides glucose for cellular energy metabolism. Lactated Ringer's solution replaces extracellular fluid and electrolytes. Lactate is metabolized to bicarbonate in the liver, providing buffering capacity for metabolic acidosis.
Intravenous infusion. Typical adult dose: 500-1000 mL as a continuous infusion at a rate of 100-200 mL/hour. Dose based on fluid and glucose requirements, typically providing 50-100 g glucose per day.
Intravenous infusion; adult dose is 500-1000 mL per 24 hours, titrated to fluid and electrolyte needs.
None Documented
None Documented
The terminal elimination half-life of glucose is approximately 1.5–2.5 hours in healthy individuals. In renal impairment, half-life may be prolonged due to reduced gluconeogenesis and altered clearance.
2–4 hours (intravenous). Clinical context: reflects glucose clearance; prolonged in renal impairment.
Excreted primarily via renal filtration; <1% is excreted unchanged in urine. The majority is metabolized to CO2 and water via glycolysis and the Krebs cycle, with CO2 eliminated via the lungs.
Renal: >99% as glucose. Biliary/fecal: negligible (<1%).
Category C
Category C
IV Fluid
IV Fluid